Advanced search×

Discrepancy between neuroimaging findings and clinical phenotype in Alexander disease.

AJNR Am J Neuroradiol 27(10):2088-92 (2006) PMID 17110673

We present a case of infantile-onset Alexander disease (AD) with a novel glial fibrillary acidic protein mutation but without clinical evidence of neurologic deterioration. Brain MRI studies showed typical AD findings and increasing size of frontal cavitations. Serial proton MR spectroscopy demonstrated high levels of myo-inositol and lactic acid and decreasing levels of N-acetylaspartate. The degree of demyelination and the timing of the axonal degeneration may determine phenotypic severity of the disease. Conventional neuroimaging techniques cannot always predict the outcome.

Version: za2963e q8zab q8zb3 q8zc2 q8zdc q8ze6 q8zfe q8zge

Similar articles you may find interesting…

  1. Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of...

    Am J Physiol Regul Integr Comp Physiol 289(4):R1048-53 (2005) PMID 15947070 PMCID 1237117

    We are unable to demonstrate any benefit in similar animals using targeted therapy directed at IL-6....
  2. Surgeons and their patients near the end of life.

    Crit Care Med 38(3):995-6 (2010) PMID 20168162

  3. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex.

    Ann Neurol 59(3):490-8 (2006) PMID 16453317

    All lesions exhibited regression and, in one case, necrosis. Interruption of therapy resulted in regrowth of subependymal giant cell astrocytomas in one patient. Resumption of therapy resulted in further regression. Treatment was well tolerated. INTERPRETATION: Oral rapamycin therapy can induce regr...